The Journal of Organic Chemistry
Article
azine (7.8 mg, 0.068 mmol) in toluene (3.4 mL) at room temperature.
The mixture was stirred at 110 °C for 5 h. After cooling to room
temperature, the solvent was removed in vacuo and then the residue
was purified by preparative TLC on silica gel (toluene/diethyl ether =
6/1) to give cis-β-lactam 11h (25.1 mg, 70%) and trans-β-lactam 11h
(3.8 mg, 11%).
2934, 2848, 1607, 1513, 1455, 1384, 1247, 1141, 1033, 832, 753, 699
cm−1; HRMS (EI): calcd for C34H37NO5 (M)+ 539.2672, found
539.2678.
Methyl (Z)-3-(4-Methoxyphenyl)-5-((3S*,4S*)-1-(4-methoxy-
phenyl)-2-oxo-4-phenylazetidin-3-yl)-2,2,6-trimethylhepta-3,5-di-
enoate (cis-11i). Yellow solid; mp 137−140 °C; 1H NMR (500 MHz,
CDCl3) δ 7.34−7.28 (m, 5H), 7.22−7.20 (m, 2H), 7.12−7.11 (m,
2H), 6.83-6.80 (m, 2H), 6.75−6.72 (m, 2H), 5.50 (s, 1H), 5.18 (d, J
= 5.8 Hz, 1H), 4.51 (d, J = 5.8 Hz, 1H), 3.77 (s, 3H), 3.76 (s, 3H),
3.63 (s, 3H), 1.40 (s, 3H), 1.32 (s, 3H), 1.18 (s, 3H), 1.12 (s, 3H);
13C{1H} NMR (125 MHz, CDCl3) δ 177.3, 165.7, 158.0, 155.8,
145.7, 135.7, 133.2, 132.4, 131.8, 130.0, 128.2, 127.9, 126.8, 126.7,
122.1, 118.2, 114.3, 112.7, 59.8, 58.8, 55.5, 55.0, 51.8, 48.3, 26.0, 25.5,
22.0, 20.6; IR (KBr) 2987, 2944, 1747, 1607, 1512, 1455, 1387, 1251,
1146, 1033, 938, 834, 565 cm−1; HRMS (EI): calcd for C34H37NO5
(M)+ 539.2672, found 539.2669.
Entry 10: In a 30 mL two-neck round-bottom flask equipped with a
magnetic stirring bar, a glass stopper, a Dimroth condenser, and an
argon balloon was placed aminocyclobutenone 10j (54.4 mg, 0.10
mmol) in octane (5.0 mL) at room temperature. The mixture was
stirred at 110 °C for 5 h. After cooling to room temperature, the
solvent was removed in vacuo and then the residue was purified by
preparative TLC on silica gel (toluene/diethyl ether = 7/1) to give
cis-β-lactam 11j (9.3 mg, 17%) and trans-β-lactam 11j (30.8 mg,
56%).
Entry 10 with DBU: In a 30 mL two-neck round-bottom flask
equipped with a magnetic stirring bar, a glass stopper, a Dimroth
condenser, and an argon balloon were placed aminocyclobutenone
10j (17.8 mg, 0.033 mmol) and DBU (5.0 mg, 0.033 mmol) in
toluene (1.7 mL) at room temperature. The mixture was stirred at
110 °C for 31 h. After cooling to room temperature, the solvent was
removed in vacuo and then the residue was purified by preparative
TLC on silica gel (hexane/ethyl acetate = 3/1) to give the mixture of
cis- and trans-β-lactams 11j (14.5 mg, 81%, cis/trans = 9/91).
Entry 10 with 1,4-dimethylpiperazine: In a 30 mL two-neck round-
bottom flask equipped with a magnetic stirring bar, a glass stopper, a
Dimroth condenser, and an argon balloon were placed amino-
cyclobutenone 10j (54.4 mg, 0.10 mmol) and 1,4-dimethylpiperazine
(11.4 mg, 0.10 mmol) in toluene (5.0 mL) at room temperature. The
mixture was stirred at 110 °C for 5 h. After cooling to room
temperature, the solvent was removed in vacuo and then the residue
was purified by preparative TLC on silica gel (toluene/diethyl ether =
7/1) to give cis-β-lactam 11j (41.1 mg, 75%) and trans-β-lactam 11j
(4.1 mg, 8%).
Methyl (Z)-5-((3R*,4S*)-1-(4-Methoxyphenyl)-2-oxo-4-phenyla-
zetidin-3-yl)-2,2,6-trimethyl-3-(p-tolyl)hepta-3,5-dienoate (trans-
1
11h). Yellow oil; H NMR (400 MHz, CDCl3) δ 7.32−7.27 (m,
3H), 7.18−7.10 (m, 4H), 6.98−6.96 (m, 2H), 6.90−6.87 (m, 2H),
6.81−6.77 (m, 2H), 6.26 (s, 1H), 4.38 (d, J = 2.8 Hz, 1H), 3.98 (d, J
= 2.8 Hz, 1H), 3.75 (s, 3H), 3.50 (s, 3H), 2.31 (s, 3H), 1.62 (s, 3H),
1.39 (s, 3H), 1.33 (s, 3H), 1.31 (s, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ 177.1, 165.5, 155.7, 146.8, 138.5, 136.4, 136.2, 134.1, 131.5,
128.9, 128.7, 128.3, 128.1, 125.9, 122.9, 118.2, 114.1, 63.4, 59.5, 55.4,
51.8, 48.4, 26.1, 26.0, 22.9, 21.2, 20.4; IR (neat) 2981, 2926, 1749,
1596, 1512, 1453, 1385, 1246, 1183, 1144, 1032, 829, 750, 698 cm−1;
HRMS (EI): calcd for C34H37NO4 (M)+ 523.2723, found 523.2726.
Methyl (Z)-5-((3S*,4S*)-1-(4-Methoxyphenyl)-2-oxo-4-phenyla-
zetidin-3-yl)-2,2,6-trimethyl-3-(p-tolyl)hepta-3,5-dienoate (cis-
1
11h). Yellow solid; mp 140−141 °C; H NMR (400 MHz, CDCl3)
δ 7.34−7.28 (m, 5H), 7.22−7.20 (m, 2H), 7.07−7.05 (m, 2H), 7.00−
6.98 (m, 2H), 6.83−6.79 (m, 2H), 5.51 (s, 1H), 5.16 (d, J = 6.0 Hz,
1H), 4.48 (d, J = 6.0 Hz, 1H), 3.76 (s, 3H), 3.63 (s, 3H), 2.28 (s,
3H), 1.39 (s, 3H), 1.32 (s, 3H), 1.18 (s, 3H), 1.13 (s, 3H); 13C{1H}
NMR (100 MHz, CDCl3) δ 177.3, 165.7, 155.8, 146.0, 136.9, 135.8,
133.2, 131.8, 128.7, 128.2, 128.0, 127.9, 126.9, 126.6, 122.1, 118.2,
114.3, 59.9, 58.8, 55.4, 51.8, 48.2, 26.0, 25.5, 22.0, 21.1, 20.7; IR
(neat) 2987, 2925, 1747, 1512, 1455, 1391, 1297, 1249, 1142, 1030,
826, 773, 697 cm−1; HRMS (EI): calcd for C34H37NO4 (M)+
523.2723, found 523.2724.
Entry 9: In a 30 mL two-neck round-bottom flask equipped with a
magnetic stirring bar, a glass stopper, a Dimroth condenser, and an
argon balloon was placed aminocyclobutenone 10i (23.8 mg, 0.044
mmol) in octane (2.2 mL) at room temperature. The mixture was
stirred at 110 °C for 5 h. After cooling to room temperature, the
solvent was removed in vacuo and then the residue was purified by
preparative TLC on silica gel (toluene/diethyl ether = 7/1) to give
cis-β-lactam 11i (4.6 mg, 17%) and trans-β-lactam 11i (16.9 mg,
63%).
Entry 9 with DBU: In a 30 mL two-neck round-bottom flask
equipped with a magnetic stirring bar, a glass stopper, a Dimroth
condenser, and an argon balloon were placed aminocyclobutenone
10i (39.4 mg, 0.073 mmol) and DBU (11.0 mg, 0.073 mmol) in
toluene (3.7 mL) at room temperature. The mixture was stirred at
110 °C for 31 h. After cooling to room temperature, the solvent was
removed in vacuo and then the residue was purified by preparative
TLC on silica gel (hexane/ethyl acetate = 3/1, twice) to give the
mixture of cis- and trans-β-lactams 11i (31.9 mg, 81%, cis/trans = 20/
80).
Entry 9 with 1,4-dimethylpiperazine: In a 30 mL two-neck round-
bottom flask equipped with a magnetic stirring bar, a glass stopper, a
Dimroth condenser, and an argon balloon were placed amino-
cyclobutenone 10i (36.5 mg, 0.068 mmol) and 1,4-dimethylpiper-
azine (7.8 mg, 0.068 mmol) in toluene (3.4 mL) at room temperature.
The mixture was stirred at 110 °C for 5 h. After cooling to room
temperature, the solvent was removed in vacuo and then the residue
was purified by preparative TLC on silica gel (toluene/diethyl ether =
7/1) to give cis-β-lactam 11i (27.1 mg, 74%) and trans-β-lactam 11i
(4.8 mg, 13%).
Methyl (Z)-3-(4-Methoxyphenyl)-5-((3R*,4S*)-1-(4-methoxy-
phenyl)-2-oxo-4-phenylazetidin-3-yl)-2,2,6-trimethylhepta-3,5-di-
enoate (trans-11i). Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.32−
7.27 (m, 3H), 7.19−7.14 (m, 4H), 6.94−6.92 (m, 2H), 6.80−6.78
(m, 2H), 6.72−6.70 (m, 2H), 6.26 (s, 1H), 4.39 (d, J = 2.4 Hz, 1H),
3.99 (d, J = 2.4 Hz, 1H), 3.78 (s, 3H), 3.75 (s, 3H), 3.51 (s, 3H), 1.61
(s, 3H), 1,39 (s, 3H), 1.33 (s, 3H), 1.32 (s, 3H); 13C{1H} NMR (125
MHz, CDCl3) δ 177.1, 165.5, 158.4, 155.8, 146.5, 138.4, 134.0, 131.6,
131.4, 129.9, 129.0, 128.1, 126.0, 125.9, 122.9, 118.2, 114.2, 113.1,
63.4, 59.7, 55.4, 55.1, 51.8, 48.6, 26.1, 26.0, 22.9, 20.4; IR (neat)
Methyl (Z)-3-(4-Chlorophenyl)-5-((3R*,4S*)-1-(4-methoxyphen-
yl)-2-oxo-4-phenylazetidin-3-yl)-2,2,6-trimethylhepta-3,5-dienoate
1
(trans-11j). Yellow solid; mp 107−109 °C; H NMR (400 MHz,
CDCl3) δ 7.35−7.29 (m, 3H), 7.20−7.13 (m, 6H), 6.99−6.96 (m,
2H), 6.81−6.77 (m, 2H), 6.30 (s, 1H), 4.43 (d, J = 2.1 Hz, 1H), 4.00
(d, J = 2.1 Hz, 1H), 3.75 (s, 3H), 3.54 (s, 3H), 1.58 (s, 3H), 1.39 (s,
3H), 1.33 (s, 3H), 1.32 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ
176.8, 165.2, 155.9, 145.8, 138.2, 137.8, 134.3, 132.9, 131.3, 130.2,
129.1, 128.3, 127.8, 126.7, 125.9, 122.7, 118.1, 114.3, 63.3, 60.0, 55.4,
51.9, 48.3, 26.1, 25.9, 22.9, 20.4; IR (KBr) 2987, 2934, 1751, 1511,
1452, 1386, 1246, 1142, 1030, 830, 731 cm−1; HRMS (EI): calcd for
C33H34ClNO4 (M)+ 543.2176, found 543.2179.
Methyl (Z)-3-(4-Chlorophenyl)-5-((3S,4S)-1-(4-methoxyphenyl)-
2-oxo-4-phenylazetidin-3-yl)-2,2,6-trimethylhepta-3,5-dienoate
(cis-11j). Yellow solid; mp 140−141 °C; 1H NMR (400 MHz,
CDCl3) δ 7.35−7.29 (m, 5H), 7.21−7.15 (m, 6H), 6.84−6.80 (m,
2H), 5.54 (s, 1H), 5.19 (d, J = 5.7 Hz, 1H), 4.51 (d, J = 5.7 Hz, 1H),
3.76 (s, 3H), 3.62 (s, 3H), 1.39 (s, 3H), 1.32 (s, 3H), 1.17 (s, 3H),
1.11 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 177.0, 165.5,
155.9, 145.1, 138.6, 135.6, 133.5, 132.3, 131.7, 130.4, 128.2, 128.0,
127.5, 127.4, 126.7, 122.0, 118.2, 114.3, 59.8, 58.5, 55.4, 51.8, 48.1,
26.0, 25.4, 22.0, 20.5; IR (KBr) 2981, 2937, 1740, 1513, 1452, 1387,
1298, 1250, 1175, 1143, 1034, 835, 776, 698 cm−1; HRMS (EI): calcd
for C33H34ClNO4 (M)+ 543.2176, found 543.2180.
Entry 11: In a 30 mL two-neck round-bottom flask equipped with a
magnetic stirring bar, a glass stopper, a Dimroth condenser, and an
U
J. Org. Chem. XXXX, XXX, XXX−XXX